Point72 »

Peregrine Pharmaceuticals shares owned by Point72

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $11M 1.0M 11.38
2024-06-30 $57k 7.9k 7.14

More positions owned by Point72

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amgen Call Option (AMGN)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
McKesson Corporation (MCK)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation (NVDA)
Adobe Systems Incorporated Call Option (ADBE)
salesforce (CRM)
Target Corporation Call Option (TGT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Analog Devices (ADI)
Micron Technology (MU)
Bristol Myers Squibb (BMY)
Cisco Systems (CSCO)
Walt Disney Company (DIS)

View all positions for Point72

Top funds holding Peregrine Pharmaceuticals

BlackRock
AltraVue Capital
Vanguard Group
Glazer Capital
Punch & Associates Investment Management
State Street Corporation
Fil
Royal Bank of Canada
Goldman Sachs Group
Alpine Associates Management
Highland Capital Management Fund Advisors
Water Island Capital
CNH Partners
Hsbc Holdings
Geode Capital Management

View all funds holding Peregrine Pharmaceuticals